Non‐alcoholic steatohepatitis: another disease of affluence

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903 · see citing works

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.

Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191 · see citing works

Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease

Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,138 · see citing works

Nonalcoholic steatohepatitis: An expanded clinical entity

Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137 · see citing works

The natural history of nonalcoholic fatty liver: A follow-up study

Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913 · see citing works

Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis

Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. G., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 808 · see citing works

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

Weltman, M., Farrell, G. C., Hall, P. D. L. Μ., Ingelman‐Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 613 · see citing works

Hepatic steatosis: Innocent bystander or guilty party?

Day, C. P., & James, O. (1998) · Hepatology · doi:10.1002/hep.510270601 · Cited by 391 · see citing works

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

James, O., & Day, C. P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80073-1 · Cited by 370 · see citing works

Not all fat is alike

Arner, P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79052-8 · Cited by 179 · see citing works

RECURRENCE OF NONALCOHOLIC STEATOHEPATITIS FOLLOWING LIVER TRANSPLANTATION1

Kim, W. R., Poterucha, J. J., Porayko, M. K., Dickson, E. R., Steers, J. L., & Wiesner, R. H. (1996) · Transplantation · doi:10.1097/00007890-199612270-00021 · Cited by 167 · see citing works

Clinical Hepatology: Profile of An Urban, Hospital–Based Practic

Byron, D., & Minuk, G. Y. (1996) · Hepatology · doi:10.1002/hep.510240410 · Cited by 146 · see citing works

PROFILE OF AN URBAN HOSPITAL BASED PRACTICE

Byron, D., & Minuk, G. Y. (1996) · Cited by 25 · see citing works

Three for the Price of One Knockout—A Mouse Model of A Congenital Peroxisomal Disorder, Steatohepatitis, and Hepatocarcinogenesis

Bass, N. M. (1999) · Hepatology · doi:10.1002/hep.510290247 · Cited by 13 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Triglyceride Metabolism in the Liver

Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170012 · Cited by 1,229 · see citing works

Liver fibrosis in overweight patients

Ratziu, V., Giral, P., Charlotte, F., Bruckert, É., Thibault, V., Theodorou, I. D., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 969 · see citing works

P EROXISOMAL β-O XIDATION AND P EROXISOME P ROLIFERATOR –A CTIVATED R ECEPTOR α: An Adaptive Metabolic System

Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 955 · see citing works

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis

Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 836 · see citing works

Non‐alcoholic fatty liver disease

Angulo, P., & Lindor, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 838 · see citing works

Dietary Habits and Their Relations to Insulin Resistance and Postprandial Lipemia in Nonalcoholic Steatohepatitis

Musso, G., Gambino, R., Michieli, F. D., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 758 · see citing works

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association

Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo‐Perin, P., & Rizzetto, M. (2002) · Hepatology · doi:10.1053/jhep.2002.30690 · Cited by 754 · see citing works

Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.

Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734 · see citing works

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726 · see citing works

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

Tilg, H., & Moschen, A. R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.005 · Cited by 470 · see citing works

Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Volti, G. L., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 456 · see citing works

Phosphatidylcholine biosynthesis and lipoprotein metabolism

Cole, L., Vance, J. E., & Vance, D. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.009 · Cited by 439 · see citing works

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

Diraison, F., Moulin, P., & Beylot, M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70061-7 · Cited by 435 · see citing works

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431 · see citing works

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

Willner, I. R., Waters, B., Patil, S. R., Reuben, A., Morelli, J., & Riely, C. A. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04667.x · Cited by 419 · see citing works

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, A. S., Fisher, R. A., Ham, J. M., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400 · see citing works

Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol

Monto, A., Alonzo, J., Watson, J. J., Grünfeld, C., & Wright, T. L. (2002) · Hepatology · doi:10.1053/jhep.2002.35064 · Cited by 360 · see citing works

Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis

Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F. K., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 355 · see citing works

Hepatic Cytochrome P450 2E1 Activity in Nondiabetic Patients With Nonalcoholic Steatohepatitis

Chalasani, N., Gorski, J. C., Asghar, M. S., Asghar, A., FORESMAN, B. H., Hall, S. D., & Crabb, D. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50095 · Cited by 346 · see citing works

Pathological Features of Fatty Liver Disease

Yeh, M. M., & Brunt, E. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.056 · Cited by 339 · see citing works

Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis

Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343 · see citing works

Hepatic steatosis in obese patients: clinical aspects and prognostic significance

Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E., & Marchesini, G. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00126.x · Cited by 312 · see citing works

Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes

Nannipieri, M., Gonzales, C., Baldi, S., Posadas‐Sánchez, R., Williams, K., Haffner, S. M., D, M. P. S. M., & Ferrannini, E. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1757 · Cited by 309 · see citing works

Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

García‐Monzón, C., Martín‐Pérez, E., Iacono, O. L., Fernández‐Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E., & Moreno‐Otero, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80301-3 · Cited by 266 · see citing works

Association Between Elevated Liver Enzymes and C-Reactive Protein

Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., Levy, Y., Brook, G. J., & Aronson, D. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000148324.63685.6a · Cited by 257 · see citing works

Triglyceride Metabolism in the Liver

Alves‐Bezerra, M., & Cohen, D. E. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00008.x · Cited by 250 · see citing works

Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

Luyckx, F., Lefebvre, P. J., & Scheen, A. J. (2000) · PubMed · Cited by 244 · see citing works

High-fat emulsion-induced rat model of nonalcoholic steatohepatitis

Zou, Y., Li, J., Lü, C., Wang, J., Ge, J., Huang, Y., Zhang, L., & Wang, Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.03.021 · Cited by 239 · see citing works

III. Peroxisomal β-oxidation, PPARα, and steatohepatitis

Reddy, J. K. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.6.g1333 · Cited by 235 · see citing works

Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient mice

Nemoto, Y., Toda, K., Ono, M., Fujikawa‐Adachi, K., Saibara, T., Onishi, S., Enzan, H., Okada, T., & Shizuta, Y. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9575 · Cited by 230 · see citing works

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†

Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228 · see citing works

Gastrointestinal complications of diabetes mellitus

Krishnan, B. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i3.51 · Cited by 226 · see citing works

Resveratrol inhibits nonalcoholic fatty liver disease in rats

Bujanda, L., Hijona, E., Larzábal, M., Beraza, M., Aldazábal, P., García‐Urkía, N., Sarasqueta, C., Cosme, Á., Irastorza, B., González, A., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-40 · Cited by 224 · see citing works

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease

Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00331-8 · Cited by 216 · see citing works

Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients

Carey, D., Cowin, G., Galloway, G. J., Jones, N. P., Richards, J. C., Biswas, N., & Doddrell, D. M. (2002) · Obesity Research · doi:10.1038/oby.2002.137 · Cited by 210 · see citing works

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

Hyogo, H., Tazuma, S., Arihiro, K., Iwamoto, K., Nabeshima, Y., Inoue, M., Ishitobi, T., Nonaka, M., & Chayama, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.030 · Cited by 206 · see citing works

The epidemiology, pathogenesis and histopathology of fatty liver disease

Levene, A., & Goldin, R. D. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04145.x · Cited by 192 · see citing works

Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases

Angelico, F., Ben, M. D., Conti, R., Francioso, S., Feole, K., Maccioni, D., Antonini, T., & Alessandri, C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02958.x · Cited by 191 · see citing works

Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice

García‐Ruíz, I., Rodríguez‐Juan, C., Díaz-Sanjuán, T., del Hoyo, P., Colina, F., Muñoz‐Yagüe, T., & Solis-Herruzo, J. A. (2006) · Hepatology · doi:10.1002/hep.21313 · Cited by 189 · see citing works

Elevated levels of serum advanced glycation end products in patients with non‐alcoholic steatohepatitis

Hyogo, H., Yamagishi, S., Iwamoto, K., Arihiro, K., Takeuchi, M., Sato, T., Ochi, H., Nonaka, M., Nabeshima, Y., Inoue, M., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04943.x · Cited by 188 · see citing works

Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease

Brunt, E. M., Ramrakhiani, S., Cordes, B. G., Neuschwander‐Tetri, B. A., Janney, C. G., Bacon, B. R., & Bisceglie, A. M. D. (2003) · Modern Pathology · doi:10.1097/01.mp.0000042420.21088.c7 · Cited by 182 · see citing works

Non‐alcoholic steatohepatitis (NASH): where are we now and where are we going?

Day, C. P. (2002) · Gut · doi:10.1136/gut.50.5.585 · Cited by 181 · see citing works

Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker fa/fa Rats

Daubioul, C., Rousseau, N., Taper, H. S., Declerck, B., Delzenne, N. M., Demeure, R., & Gallez, B. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.967 · Cited by 178 · see citing works

Hepatocellular carcinoma arising in non‐alcoholic steatohepatitis

Zen, Y., Katayanagi, K., Tsuneyama, K., Harada, K., Araki, I., & Nakanuma, Y. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01174.x · Cited by 174 · see citing works

Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography

Rockall, A., Sohaib, S., Evans, D., Kaltsas, G., Isidori, A. M., Monson, J., BESSER, G. M., Grossman, A. B., & Reznek, R. H. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490543 · Cited by 172 · see citing works

Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey

Shen, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i5.1106 · Cited by 171 · see citing works

Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993–1998)

Hess, R. S., Saunders, H., Winkle, T. J. V., & Ward, C. R. (2000) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2000.217.1166 · Cited by 167 · see citing works

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients

Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Nakahara, T., Hyogo, H., Yoneda, M., Sumida, Y., Eguchi, Y., Fujii, H., Ono, M., Kawaguchi, T., Imajo, K., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0911-1 · Cited by 166 · see citing works

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

Kimura, Y., Hyogo, H., Yamagishi, S., Takeuchi, M., Ishitobi, T., Nabeshima, Y., Arihiro, K., & Chayama, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0203-y · Cited by 160 · see citing works

Liver diseases and metabolic syndrome

Watanabe, S., Yaginuma, R., Ikejima, K., & Miyazaki, A. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2193-6 · Cited by 157 · see citing works

Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test

Guzzaloni, G., Grugni, G., Minocci, A., Moro, D., & Morabito, F. C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801224 · Cited by 157 · see citing works

Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with Type II diabetes

Bernard, S., Touzet, S., Personne, I., Lapras, V., Bondon, P.-J., Berthezène, F., & Moulin, P. (2000) · Diabetologia · doi:10.1007/s001250051481 · Cited by 153 · see citing works

Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise

Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 149 · see citing works

Obesity and liver disease

Scheen, A. J., & Luyckx, F. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0225 · Cited by 146 · see citing works

Leptin enhances TNF-α production via p38 and JNK MAPK in LPS-stimulated Kupffer cells

Shen, J., Sakaida, I., Uchida, K., Terai, S., & OKITA, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.004 · Cited by 145 · see citing works

Diseases and disorders associated with excess body weight.

Knight, J. A. (2011) · PubMed · Cited by 119 · see citing works

Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease

Panasiuk, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6198 · Cited by 121 · see citing works

Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity

Xu, K. Z., Zhu, C., Kim, M. S., Yamahara, J., & Li, Y. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.03.035 · Cited by 120 · see citing works

Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients

Chin, K., Nakamura, T., Takahashi, K. P., Sumi, K., Ogawa, Y., Masuzaki, H., Muro, S., Hattori, N., Matsumoto, H., Niimi, A., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01570-x · Cited by 119 · see citing works

Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis

Idılman, R., Mızrak, D., CORAPCIOGLU, D., Bektaş, M., Doğanay, B., Saykı, M., Çoban, Ş., Erden, E., Soykan, İ., Emral, R., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03723.x · Cited by 119 · see citing works

Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease

Lefèbvre, P., & Staels, B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00538-6 · Cited by 114 · see citing works

Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: Activation of PPAR-α

HSUNWEIHUANG, T., PENG, G., QIANLI, G., YAMAHARA, J., Roufogalis, B. D., & Li, G. Q. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.05.003 · Cited by 115 · see citing works

Autophagy Deficiency by Hepatic FIP200 Deletion Uncouples Steatosis From Liver Injury in NAFLD

Ma, D., Molusky, M. M., Song, J., Hu, C.-R., Fang, F., Rui, C., Mathew, A. V., Pennathur, S., Liu, F., Cheng, J., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1153 · Cited by 114 · see citing works

Alcoholic and nonalcoholic steatohepatitis

Brunt, E. M. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00002-8 · Cited by 113 · see citing works

The Epidemiology and Risk Factors of NASH

McCullough, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch3 · Cited by 109 · see citing works

Sympathetic Nervous System Catecholamines and Neuropeptide Y Neurotransmitters Are Upregulated in Human NAFLD and Modulate the Fibrogenic Function of Hepatic Stellate Cells

Sigala, B., McKee, C. M., Soeda, J., Pazienza, V., Morgan, M. L., Lin, C., Selden, C., Borght, S. V., Mazzoccoli, G., Roskams, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072928 · Cited by 108 · see citing works

Inflammatory Mediators of Hepatic Steatosis

Hijona, E., Hijona, L., Arenas, J. I., & Bujanda, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/837419 · Cited by 108 · see citing works

Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States

Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00395-0 · Cited by 107 · see citing works

Non‐alcoholic fatty liver disease

Alba, L. M., & Lindor, K. D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01493.x · Cited by 105 · see citing works

Efficacy of rosuvastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study

Nakahara, T., Hyogo, H., Kimura, Y., Ishitobi, T., Arihiro, K., Aikata, H., Takahashi, S., & Chayama, K. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01034.x · Cited by 103 · see citing works

Nonalcoholic steatohepatitis: risk factors for liver fibrosis

Shimada, M. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00246-2 · Cited by 102 · see citing works

Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation

Hall, P. D. L. Μ., Lieber, C. S., DeCarli, L. M., French, S. W., Lindros, K. O., Järveläinen, H. A., Bode, C., Parlesak, A., & Bode, J. C. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02405.x · Cited by 99 · see citing works

Multiple short bouts of exercise over 12-h period reduce glucose excursions more than an energy-matched single bout of exercise

Holmstrup, M., Fairchild, T., Keslacy, S., Weinstock, R., & Kanaley, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.12.006 · Cited by 98 · see citing works

NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages

Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 96 · see citing works

Non‐invasive markers to predict the liver fibrosis in non‐alcoholic fatty liver disease

Lydatakis, H., Hager, I. P., Kostadelou, E., Mpousmpoulas, S., Pappas, S. I., & Diamantis, I. D. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01312.x · Cited by 97 · see citing works

Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice

Bieghs, V., van Gorp, P. J., Walenbergh, S. M. A., Gijbels, M. J., Verheyen, F., Buurman, W. A., Briles, D. E., Hofker, M. H., Binder, C. J., & Shiri‐Sverdlov, R. (2012) · Hepatology · doi:10.1002/hep.25660 · Cited by 94 · see citing works

Gender-related variations in iron metabolism and liver diseases

Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 98 · see citing works

Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

Evans, C. D., Oien, K. A., MacSween, R. N. M., & Mills, P. R. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.9.689 · Cited by 94 · see citing works

Immature Citrus sunki Peel Extract Exhibits Antiobesity Effects by .BETA.-Oxidation and Lipolysis in High-Fat Diet-Induced Obese Mice

Kang, S., Shin, H., Kim, H.-M., Hong, Y.-S., Yoon, S., Kang, S.-W., Kim, J., Kim, M.-H., Ko, H., & Kim, S. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.223 · Cited by 92 · see citing works

Steatohepatitis in obese individuals

Youssef, W. I., & McCullough, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0334 · Cited by 92 · see citing works

From the origin of NASH to the future of metabolic fatty liver disease

Geier, A., TINIAKOS, D. G., Denk, H., & Trauner, M. A. (2021) · Gut · doi:10.1136/gutjnl-2020-323202 · Cited by 90 · see citing works

Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study

Hyogo, H., Ikegami, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., Tokumo, H., Hino, F., & Tazuma, S. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00849.x · Cited by 83 · see citing works

Correlation between Fatty Liver and Coronary Risk Factors: A Population Study of Elderly Men and Women in Nagasaki, Japan.

Akahoshi, M., AMASAKI, Y., Soda, M., Tominaga, T., Ichimaru, S., Nakashima, E., Seto, S., & Yano, K. (2001) · Hypertension Research · doi:10.1291/hypres.24.337 · Cited by 80 · see citing works

Spleen Enlargement in Patients with Nonalcoholic Fatty Liver

Tsushima, Y., & Endo, K. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005446418589 · Cited by 77 · see citing works

Liver-Specific Peroxisome Proliferator–Activated Receptor α Target Gene Regulation by the Angiotensin Type 1 Receptor Blocker Telmisartan

Clemenz, M., Frost, N., Schupp, M., Caron, S., Foryst‐Ludwig, A., Böhm, C., Hartge, M., Gust, R., Staels, B., Unger, T., et al. (2008) · Diabetes · doi:10.2337/db07-0839 · Cited by 77 · see citing works

Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease

Hajighasem, A., Farzanegi, P., & Mazaheri, Z. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1441872 · Cited by 75 · see citing works

Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet

Wang, J., Li, J., Zou, Y., Cheng, W., Lu, C., Zhang, L., Ge, J., Huang, C., Jin, Y. J., Lv, X., et al. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.029 · Cited by 74 · see citing works

Pathology of steatohepatitis

Brunt, E. M., & TINIAKOS, D. G. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0326 · Cited by 73 · see citing works

Bariatric Surgery-Induced Weight Loss Reduces Hepatic Lipid Peroxidation Levels and Affects Hepatic Cytochrome P-450 Protein Content

Bell, L. N., Temm, C. J., Saxena, R., Vuppalanchi, R., Schauer, P. R., Rabinovitz, M., Krasinskas, A. M., Chalasani, N., & Mattar, S. G. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181dbb572 · Cited by 72 · see citing works

Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease

Asanuma, T., Ono, M., Kubota, K., Hirose, A., Hayashi, Y., Saibara, T., Inanami, O., Ogawa, Y., Enzan, H., Onishi, S., et al. (2009) · Gut · doi:10.1136/gut.2009.176651 · Cited by 72 · see citing works

Petalonia binghamiae Extract and Its Constituent Fucoxanthin Ameliorate High-Fat Diet-Induced Obesity by Activating AMP-Activated Protein Kinase

Kang, S., Shin, H., Kim, H.-M., Yoon, S., Kang, S.-W., Kim, J., Ko, H., & Kim, S. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2047652 · Cited by 71 · see citing works

Restriction of dietary calories, fat and iron improves non‐alcoholic fatty liver disease

Yamamoto, M., Iwasa, M., Iwata, K., Kaito, M., Sugimoto, R., Urawa, N., Mifuji, R., Konishi, M., Kobayashi, Y., & Adachi, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04548.x · Cited by 68 · see citing works

Pediatric Nonalcoholic Fatty Liver Disease

Bozic, M. A., Subbarao, G. C., & Molleston, J. P. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613489153 · Cited by 67 · see citing works

Nonalcoholic Fatty Liver Disease and Obesity

Saadeh, S. N. (2007) · Nutrition in Clinical Practice · doi:10.1177/011542650702200101 · Cited by 66 · see citing works

Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease

Rakha, E. A., Adamson, L. M., Bell, E., Neal, K. R., Ryder, S. D., Kaye, P., & Aithal, G. P. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.079145 · Cited by 66 · see citing works

CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling

Schattenberg, J. M., Wang, Y., Rigoli, R. M., Koop, D. R., & Czaja, M. J. (2004) · Hepatology · doi:10.1002/hep.20067 · Cited by 66 · see citing works

Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis

Tatsumi, K., & Saibara, T. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.014 · Cited by 65 · see citing works

Free fatty acids – do they play a central role in type 2 diabetes?

Arner, P. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00031.x · Cited by 65 · see citing works

Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1

Kang, Q., & Chen, A. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.93 · Cited by 64 · see citing works

Non-Alcoholic Steatohepatitis and GB Virus-C/Hepatitis G Virus Infection: Is There a Causal Relationship?

Kiyosawa, K. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.236 · Cited by 5 · see citing works

Non-alcoholic Steatohepatitis

James, O. (2002) · Medicine · doi:10.1383/medc.30.12.62.28524 · Cited by 47 · see citing works

Non‐alcoholic steatohepatitis (NASH): where are we now and where are we going?

Day, C. P. (2002) · Gut · doi:10.1136/gut.50.5.585 · Cited by 181 · see citing works

Non-alcoholic steatohepatitis (NASH) and chronic hepatitis C

Pérez-Carreras, M., Castellano, G., Rivas, E., Colina, F., Álvarez, V., Tomás, E., Fuertes, A., & Solis-Herruzo, J. A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)80543-8 · Cited by 1 · see citing works

Nonalcoholic steatohepatitis (NASH) as diagnostic problem

Dutkiewicz, E., Kryczka, W., Urbaniak, A., Pabjan, P., & Kubicka, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)81067-2